No switch or Nor-Switch? ACR guidelines recommend AGAINST switch to bio similar in table AS. @RheumNow #RWCS2020 https://t.co/7WPjGLAXdZ

How to treat inflammatory eye disease scheme by Dr Alvin Wells which makes good sense #RWCS2020 @RheumNow https://t.co/8tieiMUPOZ

Drug retention with TNFi for SpA in Europe varies by country but approximately 75% at one yr. maybe with more options retention worsens like in RA. @RheumNow #RWCS2020 https://t.co/xnzZxbY7Dj

Anaphylaxis or not. fever is NOT anaphylactic. IgE has flushing, itch and hives. Cytokine release has flushing and fever Dr A Postolova #RWCS2020 @RheumNow https://t.co/qgP1vP7Yfe

Delayed hypersensitivity includes serum sickness usually at day 5 to 7. Anna Postolova says. #RWCS2020 @RheumNow https://t.co/sQFYIvDGLq

If you skin test for IgE reaction don’t test in first 2 weeks post reaction as pt is Anergic then. Sweet spot is at 6 to 8 weeks to test and de sensitive if drug is needed and serious allergic reaction Dr A Postolova #RWCS2020 @RheumNow https://t.co/jakSwJ8xOC

Most common need for desensitization drugs in Rheum are IV drugs. Infliximab, Rituximab and Tociluzimab. If severe reaction desensitize and if mild premeditate ex antihistamines and steroids if needed @RheumNow #RWCS2020 https://t.co/l6SWUPljbZ

Mast Cell Activation Syndrome. Learn it. It exists but maybe more pts think they have it than really do. Rx with mast cell stabilization. MCAS has tryptase at a high level. Input for dx Dr A Postolova #RWCS2020 @RheumNow https://t.co/mz5z2o1z8p

UPA worked quickly without new safety signals noted in SELECT AXIS for AS. Drs. Ruderman and Kavanaugh #RWCS2020 @RheumNow @RWCSmtg https://t.co/g2wkLmDtd9

Packed audience at great rheum mtg. Practical. Great interaction. #RWCS2020 @RheumNow https://t.co/UErbxolatV

Invert the topical to mild systemic Rx and beyond for atopic dermatitis if severe. Stop the cytokine and itch. Use dupilumab. MAB to IL4 receptor. Also approved in asthma. Lots more drugs coming George Martin #RWCS2020 @RheumNow https://t.co/sJxfflJX5T

Get JAKed about potential new Rx for atopic dermatitis- 3 early JAKi RCTs says Dr George Martin #RWCS2020 @RheumNow https://t.co/xMR2884fCt

Atopic dermatitis has different drivers in age and ethnic groups but it is a Th2 disease. JAK1 is impressive and downstream cytokines. Itch is a big deal. Dr George Martin #RWCS2020 @RheumNow https://t.co/wK0pL8HXwt

Topicals for psoriasis and maybe atopic dermatitis. Topical JAKi tofacitinib ointment and ruxolitinib. Topical PDE4 apremilast roflumilast crisaborole. Also tapinarof More to come. Oral TKY2 also. #RWCS2020 @RheumNow https://t.co/NpxMBn5EBr